Stay updated with breaking news from Robertm Plenge. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
EA Series Trust bought a new stake in Bristol-Myers Squibb (NYSE:BMY – Free Report) during the second quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor bought 39,579 shares of the biopharmaceutical company’s stock, valued at approximately $2,531,000. Several other institutional investors and hedge funds have also […]
Key Financial Inc increased its holdings in shares of Bristol-Myers Squibb (NYSE:BMY – Free Report) by 2.6% during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 7,062 shares of the biopharmaceutical company’s stock after acquiring an additional 182 shares during […]
Independent Advisor Alliance lowered its position in Bristol-Myers Squibb (NYSE:BMY – Free Report) by 0.7% in the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 39,610 shares of the biopharmaceutical company’s stock after selling 284 shares during the period. Independent Advisor […]
Cantor Fitzgerald restated their overweight rating on shares of Bristol-Myers Squibb (NYSE:BMY – Free Report) in a research note issued to investors on Monday morning, Benzinga reports. They currently have a $75.00 target price on the biopharmaceutical company’s stock. A number of other equities research analysts have also recently issued reports on BMY. TD Cowen […]
Hohimer Wealth Management LLC decreased its holdings in Bristol-Myers Squibb (NYSE:BMY – Free Report) by 4.6% during the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 47,352 shares of the biopharmaceutical company’s stock after selling 2,308 shares during the period. Hohimer Wealth Management LLC’s holdings in […]